Skip to main content

Table 5 Univariate and multivariate analysis for overall survival

From: Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

Valuables

Univariate analysis

Multivariate analysis

HR

95% CI

P value

HR

95% CI

P value

Age (years)

≤65 vs. > 65

0.81

0.42–1.56

0.522

   

ECOG PS

0–1 vs. 2

1.38

0.42–4.50

0.596

   

Liver metastasis

− vs. +

1.29

0.61–2.73

0.501

   

Prior irinotecan

− vs. +

1.62

0.74–3.54

0.230

2.85

1.13–7.21

0.027

NLR

≤5 vs. > 5

1.76

0.87–3.55

0.117

1.51

0.64–3.61

0.349

GPS

0 vs. 1–2

2.04

1.08–3.89

0.029

2.46

1.15–5.25

0.029

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us